DXCM — DexCom Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for DexCom, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-Q	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,708	2,731	2,456	2,724	2,579
Net Total Accounts Receivable
Net Total Receivables	429	514	713	988	1,034
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,425	3,684	3,669	4,426	4,301
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	609	890	1,136	1,185	1,403
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	4,291	4,933	5,392	6,265	6,485
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	614	721	1,839	1,556	2,932
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2,464	2,891	3,260	4,196	4,382
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,827	2,042	2,132	2,069	2,103
Total Liabilities & Shareholders' Equity	4,291	4,933	5,392	6,265	6,485
Total Common Shares Outstanding